MCID: ATM003
MIFTS: 59

Autoimmune Thyroiditis malady

Categories: Rare diseases, Endocrine diseases, Immune diseases

Aliases & Classifications for Autoimmune Thyroiditis

About this section

Aliases & Descriptions for Autoimmune Thyroiditis:

Name: Autoimmune Thyroiditis 10 45 12 65
Chronic Lymphocytic Thyroiditis 10 45
Hashimoto's Syndrome 10 45
Hashimoto's Disease 10 45
Lymphocytic Thyroiditis 10
Thyroiditis, Autoimmune 36
Hashimoto's Thyroiditis 10
 
Hashimotos Thyroiditis 47
Hashimoto Thyroiditis 10
Thyroiditis, Chronic 45
Thyroiditis Chronic 47
Hashimoto's Struma 45
Hashimoto Disease 65

Classifications:



External Ids:

Disease Ontology10 DOID:7188
ICD1027 E06.3, E06.2
MeSH36 D013967
NCIt42 C38766
UMLS65 C0920350, C0677607

Summaries for Autoimmune Thyroiditis

About this section
NIH Rare Diseases:45 Hashimoto’s syndrome is a form of chronic inflammation that can damage the thyroid, reducing its ability to produce hormones (hypothyroidism). an early sign of the condition may be enlargement of the thyroid (called a goiter), which can potentially interfere with breathing or swallowing. other signs and symptoms may include tiredness, weight gain, thin and dry hair, joint or muscle pain, constipation, cold intolerance, and/or a slowed heart rate. affected women may have irregular menstrual periods or difficulty becoming pregnant. hashimoto’s syndrome is the most common cause of hypothyroidism in the united states. it is more common in women than in men, and it usually appears in mid-adulthood. the exact cause is unknown but it is thought to result from a combination of genetic and environmental factors. treatment is not always needed, but may include taking synthetic thyroid hormone. last updated: 6/30/2015

MalaCards based summary: Autoimmune Thyroiditis, also known as chronic lymphocytic thyroiditis, is related to autoimmune thyroid disease 4 and hashimoto thyroiditis. An important gene associated with Autoimmune Thyroiditis is TG (Thyroglobulin), and among its related pathways are Thyroxine (Thyroid Hormone) Production and CTLA4 Signaling. The drugs thyroid (beef) and thyroglobulin have been mentioned in the context of this disorder. Affiliated tissues include thyroid gl, thyroid and heart, and related mouse phenotypes are no phenotypic analysis and tumorigenesis.

Disease Ontology:10 An autoimmune disease of endocrine system that involves inflammation located in thyroid gland caused by the immune system reacting against its own tissues.

Wikipedia:68 Autoimmune thyroiditis, (or Chronic Autoimmune thyroiditis), is a disease in which the body interprets... more...

Related Diseases for Autoimmune Thyroiditis

About this section

Diseases in the Thyroiditis family:

Acute Thyroiditis Subacute Thyroiditis
autoimmune thyroiditis

Diseases related to Autoimmune Thyroiditis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 788)
idRelated DiseaseScoreTop Affiliating Genes
1autoimmune thyroid disease 433.1AIRE, FOXP3, IFNG, IL10, TNF
2hashimoto thyroiditis32.1CALCA, CTLA4, IFNG, IL4, PTPN22, TG
3thyroiditis30.9IL6, TG, TPO
4autoimmune polyglandular syndrome type 230.8CTLA4, HLA-DQB1, TNF
5accommodative spasm30.3CTLA4, TG, TPO
6crohn's disease30.1IL6, TNF
7infertility30.1FOXP3, IFNG
8achalasia29.9IL10, IL4, TNF
9endemic goiter29.8CALCA, CXCL10, TG, TPO
10hypoglycemia29.8IFNG, IL2, IL4
11meningitis29.8IL10, IL1B, TNF
12cholera29.7IL10, IL6, TNF
13vernal conjunctivitis29.6AIRE, IFNG, IL10, IL4
14vulvar disease29.6AIRE, IFNG, IL10, PTPN22
15porphyria29.3IFNG, IL1B, TNF
16periodontal disease29.3IL1B, IL6, TNF
17food allergy29.1IFNG, IL10, IL1B, TNF
18lateral sclerosis29.0IL10, IL1B, IL6, TNF
19degenerative disc disease29.0FOXP3, IFNG, IL10, IL2, IL4, TNF
20neonatal respiratory failure29.0IL10, IL1B, IL6, TNF
21lymphedema29.0IL1B, IL4, IL6, TNF
22bone cancer28.8CALCA, HLA-DQB1, IL10, IL1B, TG, TPO
23gingival overgrowth28.7IL10, IL1B, IL4, IL6, TNF
24cutaneous leishmaniasis28.7IFNG, IL10, IL1B, IL6, TNF
25asthma28.6HLA-DQB1, IFNG, IL10, IL1B, IL4, IL6
26tracheal stenosis28.4CALCA, IFNG, IL10, IL1B, IL6, TNF
27systemic lupus erythematosus28.3CTLA4, CXCL10, HLA-DQB1, IFNG, IL10, IL2
28rheumatoid arthritis27.4CTLA4, FOXP3, HLA-DQB1, IFNG, IL10, IL1B
29subacute lymphocytic thyroiditis12.6
30autoimmune thyroid disease 312.6
31autoimmune thyroid disease 212.5
32autoimmune thyroid disease 112.4
33hashimoto's encephalitis11.5
34lymphomatous thyroiditis11.4
35autoimmune polyendocrinopathy type 211.4
36autoimmune polyglandular syndrome type 310.6
37thyroid ectopia10.6TG, TPO
38neonatal meningitis10.6TG, TPO
39rhabdomyosarcoma, embryonal, 210.5TG, TPO
40autoimmune thyroiditis10.5IL2, TG, TPO
41stomach disease10.5FOXP3, TG
42laryngeal mucoepidermoid carcinoma10.4CALCA, TG
43frontal convexity meningioma10.4CTLA4, TG, TPO
44skin angiosarcoma10.4CALCA, TG
45ureterocele10.3IL2, TNF
46limbic encephalitis with ncmags antibodies10.3IFNG, IL2, IL4
47punctate palmoplantar keratoderma type 210.3IL10, TNF
48peanut allergy10.3FOXP3, HLA-DQB1, IL4
49megaloblastic anemia10.3AIRE, TG, TPO
50dysgammaglobulinemia10.3IL10, IL4

Graphical network of the top 20 diseases related to Autoimmune Thyroiditis:



Diseases related to autoimmune thyroiditis

Symptoms for Autoimmune Thyroiditis

About this section

Drugs & Therapeutics for Autoimmune Thyroiditis

About this section

Drugs for Autoimmune Thyroiditis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 131)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Glatiramer Acetateapproved, investigationalPhase 494147245-92-93081884
Synonyms:
(2S)-2,6-diaminohexanoic acid
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-aminopentanedioic acid
(2S)-2-aminopropanoic acid
147245-92-9
AC1MIXQC
Aventis brand of copolymer 1
C089995
CID3081884
COP-1
Copaxone
Copolymer 1
 
Copolymer-1
Copoylmer 1
Glatiramer acetate
Glatiramer acetate [USAN]
L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt)
L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)
LS-186971
LS-71889
TV 5010
TV-5010
TV5010
Teva brand of copolymer 1
UNII-5M691HL4BO
acetic acid
2Protective AgentsPhase 4, Phase 2, Phase 15651
3
SeleniumPhase 4, Phase 21667782-49-2
Synonyms:
Selanediide
Selenide
 
Selenide(2-)
Selenium
Selenium ion (Se2+)
4MicronutrientsPhase 4, Phase 23901
5Trace ElementsPhase 4, Phase 23900
6AntioxidantsPhase 4, Phase 22442
7Antirheumatic AgentsPhase 4, Phase 3, Phase 2, Phase 18496
8Adjuvants, ImmunologicPhase 41783
9Immunologic FactorsPhase 4, Phase 3, Phase 1, Phase 218483
10Immunosuppressive AgentsPhase 4, Phase 310422
11Contraceptives, OralPhase 43734
12Contraceptive AgentsPhase 41706
13methionineNutraceuticalPhase 473
14
DopamineapprovedPhase 3308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
15
AdalimumabapprovedPhase 3, Phase 2443331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
16
Aripiprazoleapproved, investigationalPhase 3, Phase 1342129722-12-960795
Synonyms:
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
Abilify
Abilify (TN)
Abilify DISCMELT
Abilify Discmelt
Abilify Maintena
Abilitat
Aripiprazol
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
Aripiprazolum
Aripirazole
Arpizol
Asprito|
BMS-337039
Bio-0004
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
CHEMBL1112
CID60795
 
CPD000466383
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
OPC 31
OPC-14597
OPC-31
Opc 14597
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
aripiprazol
aripiprazole
aripiprazolum
||OPC 14597
17
AzithromycinapprovedPhase 332283905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
18
Palivizumabapproved, investigationalPhase 324188039-54-5
Synonyms:
188039-54-5
D02737
Palivizumab
Palivizumab (INN)
 
Palivizumab (genetical recombination)
Palivizumab (genetical recombination) (JAN)
Synagis
Synagis (TN)
anti-RSV
19
Naltrexoneapproved, investigationalPhase 3, Phase 134916590-41-35360515
Synonyms:
16590-41-3
16676-29-2
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one
BIDD:GT0405
BPBio1_000146
BRD-K88172511-310-03-8
BRN 3596648
BSPBio_000132
C07253
CCRIS 3506
CHEBI:121459
CHEBI:7465
CHEMBL142
CID5360515
Celupan
D05113
DB00704
Depade
EINECS 240-649-9
EN-1639A
HMS2089O11
HS-0002
HSDB 6750
LS-92094
MLS002153483
MolPort-004-920-221
MorViva
 
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
N-Cyclopropylmethylnoroxymorphone
Naltrexon
Naltrexona
Naltrexona [INN-Spanish]
Naltrexone
Naltrexone (USAN/INN)
Naltrexone Hcl
Naltrexone Hydrochloride
Naltrexone [USAN:BAN:INN]
Naltrexone [USAN:INN:BAN]
Naltrexone [Usan:Ban:Inn]
Naltrexonum
Naltrexonum [INN-Latin]
PDSP2_000847
PTI-555
Prestwick0_000116
Prestwick1_000116
Prestwick2_000116
Prestwick3_000116
ReVia
Revia
SMP1_000206
SPBio_002071
UM-792
UNII-5S6W795CQM
Vivitrex
Vivitrol
Vivitrol (TN)
naltrexone
naltrexone (ReVia)
20
Etanerceptapproved, investigationalPhase 3383185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
21
MethotrexateapprovedPhase 314441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
22Antiviral AgentsPhase 3, Phase 1, Phase 28071
23AntibodiesPhase 3, Phase 14477
24Antibodies, MonoclonalPhase 32413
25Anti-Inflammatory AgentsPhase 3, Phase 2, Phase 18478
26Gastrointestinal AgentsPhase 3, Phase 26401
27ImmunoglobulinsPhase 3, Phase 14477
28BrexpiprazolePhase 331
29Dopamine AgonistsPhase 3544
30Central Nervous System DepressantsPhase 3, Phase 110016
31Dopamine AgentsPhase 33084
32Anti-Infective AgentsPhase 3, Phase 1, Phase 217220
33Antipsychotic AgentsPhase 3, Phase 12130
34Tranquilizing AgentsPhase 3, Phase 13597
35Serotonin AgentsPhase 32668
36
SerotoninPhase 3314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
37Neurotransmitter AgentsPhase 3, Phase 1, Phase 214795
38Psychotropic DrugsPhase 3, Phase 15501
39Anti-Inflammatory Agents, Non-SteroidalPhase 3, Phase 13549
40Analgesics, Non-NarcoticPhase 3, Phase 15184
41AnalgesicsPhase 3, Phase 19358
42
nalmefenePhase 3, Phase 11855096-26-95284594
Synonyms:
(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol
(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinon-3,14-diol
(5alpha)-17-(cyclopropylmethyl)-6-methylidene-4,5-epoxymorphinan-3,14-diol
17-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol
55096-26-9
58895-64-0 (hydrochloride)
6-Desoxy-6-methylenenaltrexone
9a-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylen-3,14-morphinandiol
Alcofene
Arthene
C08027
CHEBI:200696
CHEMBL982
CID5284594
Cervene
Cessal
D05111
HSDB 6761
Incystene
JF 1
JF-1
LS-91713
 
MLS000069366
MolPort-003-959-014
N5770_SIGMA
NCGC00021666-03
NIH-10365
Nalmefene (USAN/INN)
Nalmefene [USAN:BAN:INN]
Nalmefeno
Nalmefeno [INN-Spanish]
Nalmefenum
Nalmefenum [INN-Latin]
Nalmetrene
Nalmetreno
Nalmetreno [INN-Spanish]
Nalmetrenum
Nalmetrenum [INN-Latin]
ORF 11676
ORF-11676
PDSP2_001543
Revex
SMR000058884
Soberal
UNII-TOV02TDP9I
nalmefene
43Narcotic AntagonistsPhase 3, Phase 1814
44NarcoticsPhase 3, Phase 12709
45Peripheral Nervous System AgentsPhase 3, Phase 118510
46Phase 3
47
rituximabapprovedPhase 1, Phase 21582174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
48
TolvaptanapprovedPhase 284150683-30-0216237, 443894
Synonyms:
( -)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide
150683-30-0
7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine
AC1L50C9
C116664
CHEBI:327437
CHEMBL344159
CID216237
 
L001628
N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
OPC 41061
OPC-41061
PDSP1_001738
PDSP2_001721
Samsca
Tolvaptan
UNII-21G72T1950
benzazepine derivative, 32
49
AldesleukinapprovedPhase 1, Phase 238785898-30-2
Synonyms:
IL-2
Interleukin-2 precursor
 
Proleukin
T-cell growth factor
TCGF
50
MetronidazoleapprovedPhase 2418443-48-14173
Synonyms:
1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(β-oxyethyl)-2-methyl-5-nitroimidazole
1-Hydroxyethyl-2-methyl-5-nitroimidazole
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
2-Methyl-5-nitro-1-imidazoleethanol
2-Methyl-5-nitroimidazole-1-ethanol
2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-methyl-5-nitroimidazole-1-ethanol
443-48-1
46461_FLUKA
46461_RIEDEL
69198-10-3 (mono-hydrochloride)
99616-64-5
AB00052046
AC-10556
AC1L1HKS
AC1Q2P2Z
AKOS000269646
APMN
ARONIS24285
Acromona
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAS 02983617
BAY-5360
BCBcMAP01_000184
BIDD:GT0107
BPBio1_000004
BRD-K52020312-001-05-2
BRN 0611683
BSPBio_000002
BSPBio_002031
Bayer 5360
Bexon
Bio-0694
CAS-443-48-1
CB-01-14 MMX
CCRIS 410
CHEBI:39845
CHEBI:6909
CHEMBL137
CID4173
CONT
CPD000058175
Caswell No. 579AA
Clont
D00409
DB00916
Danizol
Deflamon
Deflamon-wirkstoff
DivK1c_000007
EINECS 207-136-1
EPA Pesticide Chemical Code 120401
Efloran
Elyzol
Entizol
Eumin
FLAGYL I.V. RTU IN PLASTIC CONTAINER
Flagemona
Flagesol
Flagil
Flagyl
Flagyl (TN)
Flagyl 375
Flagyl Er
Flagyl I.V.
Flagyl I.V. RTU
Flegyl
Florazole
Fossyol
Giatricol
Ginefla vir
Gineflavir
HMS1568A04
HMS1920N19
HMS2051G07
HMS2090B19
HMS2091F14
HMS500A09
HMS547C19
HSDB 3129
I14-0667
IDI1_000007
IDR-90105
KBio1_000007
KBio2_001515
KBio2_004083
KBio2_006651
KBio3_001531
KBioGR_000559
KBioSS_001515
Klion
Klont
LS-1264
M0924
M1547_SIGMA
M3761_FLUKA
M3761_SIGMA
M9036_SIGMA
METRO I.V
METRONIDAZOLE USP
MLS000028590
MLS000758286
Maybridge1_001999
Meronidal
Methronidazole
Methyl-5-nitroimidazole-1-ethanol
Metric
Metric 21
Metro Cream
Metro Gel
 
Metro I.V.
Metro I.V. In Plastic Container
MetroCream
MetroGel
MetroGel-Vaginal
MetroLotion
Metrocream
Metrodzhil
Metrogel
Metrogel-vaginal
Metrogel-vaginal (TN)
Metrogyl
Metrolag
Metrolotion
Metrolyl
Metromidol
Metronidaz
Metronidazol
Metronidazol [INN-Spanish]
Metronidazole
Metronidazole (JP15/USP/INN)
Metronidazole Benzoate
Metronidazole Monohydrochloride
Metronidazole Phosphoester
Metronidazole Topical Gel
Metronidazole [USAN:INN:BAN:JAN]
Metronidazole hydrochloride
Metronidazole in Plastic Container
Metronidazolo
Metronidazolo [DCIT]
Metronidazolum
Metronidazolum [INN-Latin]
Metrotop
Metrozine
Metryl
Mexibol
Mexibol 'silanes'
MolPort-000-141-892
MolPort-002-502-101
Monagyl
Monasin
NCGC00016446-01
NCGC00016446-02
NCGC00022059-03
NCGC00022059-04
NCGC00022059-05
NCIOpen2_000337
NIDA
NINDS_000007
NSC 50364
NSC 69587
NSC-50364
NSC50364
NSC69587
Nalox
Nidagel
Noritate
Noritate (TN)
Novonidazol
Orvagil
Prestwick0_000081
Prestwick1_000081
Prestwick2_000081
Prestwick3_000081
Prestwick_334
Protostat
RP 8823
RP-8823
Rathimed
Rosadan
Rosased
S1907_Selleck
SAM001247010
SBB041018
SC 10295
SMP1_000189
SMR000058175
SPBio_000666
SPBio_001941
SPECTRUM1500412
STK177359
Sanatrichom
Satric
Spectrum2_000883
Spectrum3_000506
Spectrum4_000060
Spectrum5_001289
Spectrum_001035
Takimetol
Trichazol
Trichex
Tricho cordes
Tricho-gynaedron
Trichocide
Trichomol
Trichomonacid 'pharmachim'
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
UNII-140QMO216E
Vagilen
Vagimid
Vandazole
Vertisal
WLN: T5N CNJ A2Q B1 ENW
WLN: T5N CNJA2Q B1 ENW
WLN: T6NTJ DQ ANU1- ET5N CNJ A1 BNW
Wagitran
ZERO/004064
ZINC00113442
Zadstat
Zidoval
giniflavir
metronidazole
neo-Tric

Interventional clinical trials:

(show top 50)    (show all 72)
idNameStatusNCT IDPhase
1Glatiramer Acetate for Multiple Sclerosis With Autoimmune ComorbiditiesCompletedNCT01456416Phase 4
2Selenium Supplementation in Youths With Autoimmune ThyroiditisRecruitingNCT02644707Phase 4
3Selenium Supplementation in PregnancyRecruitingNCT01465867Phase 4
4Post Partum Thyroiditis 2: Long Term ObservationsActive, not recruitingNCT00287144Phase 4
5A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial RhinosinusitisCompletedNCT00393835Phase 3
6Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute SchizophreniaCompletedNCT02054702Phase 3
7Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode SchizophreniaCompletedNCT02013622Phase 3
8Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work EnvironmentCompletedNCT02013609Phase 3
9Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety SymptomsCompletedNCT02013531Phase 3
10Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive TherapyCompletedNCT02012218Phase 3
11Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical ConditionsCompletedNCT01466062Phase 3
12Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid ArthritisCompletedNCT00690573Phase 3
13Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00603993Phase 3
14A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00647491Phase 2, Phase 3
15Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00235872Phase 3
16A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol DependenceRecruitingNCT02382276Phase 3
17Low Level Laser Therapy for Autoimmune ThyroiditisActive, not recruitingNCT02240563Phase 2, Phase 3
18Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)Active, not recruitingNCT02115750Phase 3
19A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)Active, not recruitingNCT02364947Phase 3
20Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and IrritabilityTerminatedNCT02212613Phase 3
21Low-Level Laser Therapy in Chronic Autoimmune ThyroiditisCompletedNCT01129492Phase 2
22Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)CompletedNCT01551498Phase 2
23Rituximab in IgG4-related Disease: A Phase 1-2 TrialCompletedNCT01584388Phase 1, Phase 2
24Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00235833Phase 2
25A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck CancerCompletedNCT02085460Phase 2
26Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled TrialRecruitingNCT01896388Phase 1, Phase 2
27Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled TrialRecruitingNCT02305134Phase 1, Phase 2
28A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or HemodiafiltrationRecruitingNCT02331680Phase 2
29Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AITActive, not recruitingNCT02302768Phase 2
30A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid LeukemiaActive, not recruitingNCT01961882Phase 2
31IL-2 in Refractory Autoimmune EncephalitisNot yet recruitingNCT02714959Phase 1, Phase 2
32Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in AphasiaNot yet recruitingNCT02226796Phase 1, Phase 2
33Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. PyloriNot yet recruitingNCT02761005Phase 2
34A Study of Sustained-Release Liothyronine Sodium (T3) in Healthy SubjectsCompletedNCT01581463Phase 1
35A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male SubjectsCompletedNCT02334787Phase 1
36A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With SchizophreniaCompletedNCT02220712Phase 1
37Infections and Autoimmunity: Autobodies Screening in Multiple SclerosisRecruitingNCT00230204Phase 1
38Pharmacodynamic Study of Cilostazol in Healthy VolunteersRecruitingNCT02554721Phase 1
39Phase 1 Study of SGI-110 in Patients With Acute Myeloid LeukemiaActive, not recruitingNCT02293993Phase 1
40A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal CancerActive, not recruitingNCT01801930Phase 1
41A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male SubjectsActive, not recruitingNCT02679469Phase 1
42Oxidative Status in Children With Autoimmune ThyroiditisCompletedNCT02318160
43Selenium Treatment in Autoimmune Thyroiditis (AIT)CompletedNCT00271427
44Cervarix Long-term Safety SurveillanceCompletedNCT01498627
45Isolated ACTH Deficiency in Patients With Hashimoto ThyroiditisCompletedNCT00552487
46Autoimmune Thyroid Disease Genetic StudyCompletedNCT00958113
47The Effect of Hydroxychloroquine Treatment in Hashimoto's ThyroiditisCompletedNCT01760421
48Hashimotos Thyroiditis and Thyroid CancerCompletedNCT01428167
49Sonographic and Laboratory Evaluation of the Thyroid Gland in Patients With Systemic SclerosisCompletedNCT01270425
50Fetuin A in Hashimoto ThyroiditisCompletedNCT01884649

Search NIH Clinical Center for Autoimmune Thyroiditis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: thyroiditis, autoimmune

Genetic Tests for Autoimmune Thyroiditis

About this section

Anatomical Context for Autoimmune Thyroiditis

About this section

MalaCards organs/tissues related to Autoimmune Thyroiditis:

33
Thyroid, Heart, Myeloid, Liver, T cells, Breast, Lung

FMA organs/tissues related to Autoimmune Thyroiditis:

16
Thyroid gl

Animal Models for Autoimmune Thyroiditis or affiliated genes

About this section

MGI Mouse Phenotypes related to Autoimmune Thyroiditis:

38 (show all 18)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00030128.2AIRE, FOXP3, IFNG, IL10, IL2, IL4
2MP:00020067.8AIRE, IFNG, IL10, IL1B, IL2, IL6
3MP:00053917.6AIRE, FOXP3, IFNG, IL10, IL4, IL6
4MP:00107717.6CTLA4, FOXP3, IFNG, IL10, IL1B, IL4
5MP:00053907.3CTLA4, IFNG, IL10, IL1B, IL4, IL6
6MP:00053897.2AIRE, FOXP3, HLA-DQB1, IFNG, IL10, IL2
7MP:00036316.8AIRE, CXCL10, HLA-DQB1, IFNG, IL10, IL1B
8MP:00053706.8AIRE, CTLA4, FOXP3, HLA-DQB1, IFNG, IL10
9MP:00053886.7AIRE, CTLA4, FOXP3, HLA-DQB1, IFNG, IL10
10MP:00053816.7AIRE, CTLA4, FOXP3, HLA-DQB1, IFNG, IL10
11MP:00053846.6AIRE, CXCL10, FOXP3, HLA-DQB1, IFNG, IL10
12MP:00053796.4AIRE, CTLA4, FOXP3, HLA-DQB1, IFNG, IL10
13MP:00053856.3CTLA4, CXCL10, FOXP3, HLA-DQB1, IFNG, IL10
14MP:00053786.3AIRE, FOXP3, HLA-DQB1, IFNG, IL10, IL2
15MP:00107685.5AIRE, CTLA4, CXCL10, FOXP3, HLA-DQB1, IFNG
16MP:00053765.3AIRE, CTLA4, CXCL10, FOXP3, HLA-DQB1, IFNG
17MP:00053875.2AIRE, CTLA4, CXCL10, FOXP3, HLA-DQB1, IFNG
18MP:00053974.8AIRE, CTLA4, CXCL10, FOXP3, HLA-DQB1, IFNG

Publications for Autoimmune Thyroiditis

About this section

Articles related to Autoimmune Thyroiditis:

(show top 50)    (show all 933)
idTitleAuthorsYear
1
Effect of ozone to remineralize initial enamel caries: in situ study. (26759338)
2016
2
Anatomic Derkay Score Is Associated with Voice Handicap in Laryngeal Papillomatosis in Adults. (26908550)
2016
3
Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype. (25689617)
2015
4
PTPN1 is recurrently mutated in lymphoid cancers. (24706663)
2014
5
Increased levels of deleted in malignant brain tumours 1 (DMBT1) in active bacteria-related appendicitis. (22296301)
2012
6
Anorexia nervosa--a noradrenergic dysregulation hypothesis. (22326200)
2012
7
Update on the pathophysiology and management of idiopathic intracranial hypertension. (22423118)
2012
8
A new method measuring the interaction between von Willebrand factor and coagulation factor VIII. (21094987)
2011
9
Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin I^7. (21398606)
2011
10
External beam radiotherapy of bladder carcinoma: considerations in determining the irradiation field margins. (20941815)
2010
11
Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin. (20519648)
2010
12
The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. (20502714)
2010
13
Autosomal dominant leukodystrophy caused by lamin B1 duplications a clinical and molecular case study of altered nuclear function and disease. (20816241)
2010
14
Massage therapy techniques as pain management for erythromelalgia: a case report. (21589683)
2010
15
Exclusion of candidate genes in seven Turkish families with autosomal recessive amelogenesis imperfecta. (19530186)
2009
16
Biological significance of prolactin in gynecologic cancers. (19491263)
2009
17
Adaptive evolution and functional redesign of core metabolic proteins in snakes. (18493604)
2008
18
Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas. (18203781)
2008
19
Outpatient rehabilitation in patients with coronary artery and peripheral arterial occlusive disease. (18373990)
2008
20
Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder. (18665321)
2008
21
Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. (17541233)
2007
22
The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms. (17529924)
2007
23
Effects of human peritoneal mesothelial cells on angiogenesis factor expression and secretion of ovarian carcinoma cells]. (17366783)
2006
24
Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. (16778060)
2006
25
Genetic epidemiology of skeletal system aging in apparently healthy human population. (15621207)
2005
26
Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. (12833155)
2003
27
Molluscum contagiosum. (12639455)
2003
28
Apolipoprotein A-V. A novel apolipoprotein associated with an early phase of liver regeneration. (11577099)
2001
29
Pulmonary nocardiosis in a patient with human immunodeficiency virus. (11419994)
2001
30
A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth. (11023856)
2000
31
Angiogenic and immune parameters during recombinant interferon-alpha2b adjuvant treatment in patients with melanoma. (11417749)
2000
32
Inorganic polyphosphate: a molecule of many functions. (10872445)
1999
33
Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. (10413676)
1999
34
RNA and protein interactions modulated by protein arginine methylation. (9752719)
1998
35
Legionella pneumonia--epidemiology, clinical characteristics and development of diagnosis]. (9796341)
1998
36
Leucocyte and platelet-derived bioactive substances in stored blood: effect of prestorage leucocyte filtration. (9186539)
1997
37
Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. (9237699)
1997
38
Pulsed flow cascade filtration. Long-term experience in low density lipoprotein and lipoprotein a removal. (8944924)
1996
39
Characterization of a DNA sequence family in the Prader-Willi/Angelman syndrome chromosome region in 15q11-q13. (8486372)
1993
40
Autoimmune reactivity in sheep induced by the visna retrovirus. (8384456)
1993
41
Prothymosin alpha expression in lymph nodes and tonsils: an optical and ultrastructural study. (1632187)
1992
42
Pneumoconiosis in carbon electrode workers. (3230438)
1988
43
Megacystis-microcolon-intestinal hypoperistalsis syndrome: a functional intestinal obstruction in the female newborn. (3984525)
1985
44
BCG-induced orchitis: structural changes during the degeneration of seminiferous tubules of rats and rabbits. (7051504)
1982
45
Management of herpetic keratitis. (7046194)
1982
46
Bladder neck obstruction and associated lesions in children. (13439696)
1957
47
48
49
50

Variations for Autoimmune Thyroiditis

About this section

Expression for genes affiliated with Autoimmune Thyroiditis

About this section
Search GEO for disease gene expression data for Autoimmune Thyroiditis.

Pathways for genes affiliated with Autoimmune Thyroiditis

About this section

Pathways related to Autoimmune Thyroiditis according to GeneCards Suite gene sharing:

(show top 50)    (show all 53)
idSuper pathwaysScoreTop Affiliating Genes
110.0TG, TPO
29.6CTLA4, HLA-DQB1, PTPN22
39.6IFNG, IL2, IL4
49.4CXCL10, IFNG, IL1B
5
Show member pathways
9.4IFNG, IL2, TNF
69.2IFNG, IL10, IL2, IL4
79.1IFNG, IL1B, TNF
89.1CXCL10, IL1B, IL6
9
Show member pathways
9.0IFNG, IL1B, IL2, IL4
109.0IL1B, IL4, IL6
118.9IFNG, IL2, IL4, IL6
128.8IFNG, IL10, IL2, IL6
138.8IL1B, IL6, TNF
148.8FOXP3, IFNG, IL10, IL2, IL4
158.7IFNG, IL2, IL6, TNF
16
Show member pathways
8.7IFNG, IL1B, IL4, IL6
17
Show member pathways
8.6FOXP3, IFNG, IL10, IL2, TNF
188.5CXCL10, IL1B, IL6, TNF
19
Show member pathways
8.5IFNG, IL10, IL2, IL4, IL6
208.5IL1B, IL4, IL6, TNF
21
Show member pathways
8.5IFNG, IL1B, IL6, TNF
22
Show member pathways
8.5IFNG, IL1B, IL6, TNF
23
Show member pathways
8.4CTLA4, FOXP3, IFNG, IL2, IL4, TNF
248.4IL10, IL1B, IL6, TNF
258.4IL10, IL1B, IL6, TNF
268.4IL10, IL1B, IL6, TNF
278.3CALCA, IFNG, IL1B, IL6, TNF
288.1IFNG, IL10, IL1B, IL2, IL4, TNF
298.1IFNG, IL10, IL1B, IL6, TNF
308.1IFNG, IL10, IL1B, IL6, TNF
318.1IFNG, IL10, IL1B, IL6, TNF
32
Show member pathways
8.1HLA-DQB1, IFNG, IL10, IL1B, IL4, TNF
338.0IFNG, IL10, IL2, IL4, IL6, TNF
348.0CTLA4, FOXP3, IL10, IL4, IL6, TNF
357.9CTLA4, HLA-DQB1, IFNG, IL1B, IL6, TNF
36
Show member pathways
7.8IFNG, IL10, IL1B, IL2, IL6, TNF
377.8IFNG, IL10, IL1B, IL2, IL6, TNF
38
Show member pathways
7.8IFNG, IL10, IL1B, IL2, IL6, TNF
397.7HLA-DQB1, IFNG, IL10, IL1B, IL6, TNF
407.6CXCL10, IFNG, IL1B, IL2, IL4, IL6
417.5IFNG, IL10, IL1B, IL2, IL4, IL6
42
Show member pathways
7.5IFNG, IL10, IL1B, IL2, IL4, IL6
43
Show member pathways
7.3CXCL10, HLA-DQB1, IFNG, IL1B, IL2, IL4
44
Show member pathways
7.3CXCL10, HLA-DQB1, IFNG, IL1B, IL2, IL4
45
Show member pathways
7.1CXCL10, CXCL11, IFNG, IL1B, IL4, IL6
46
Show member pathways
6.7CXCL10, CXCL11, IL10, IL1B, IL2, IL4
47
Show member pathways
6.7CXCL10, CXCL11, IFNG, IL10, IL1B, IL2
48
Show member pathways
6.5CXCL10, CXCL11, IL10, IL1B, IL2, IL4
49
Show member pathways
6.4CXCL10, CXCL11, IFNG, IL10, IL1B, IL2
50
Show member pathways
6.1CTLA4, FOXP3, HLA-DQB1, IFNG, IL10, IL1B

GO Terms for genes affiliated with Autoimmune Thyroiditis

About this section

Biological processes related to Autoimmune Thyroiditis according to GeneCards Suite gene sharing:

(show top 50)    (show all 69)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of T-helper 17 cell differentiationGO:200032010.6FOXP3, IL4
2type 2 immune responseGO:004209210.4IL10, IL4
3positive regulation of mononuclear cell migrationGO:007167710.4IL4, TNF
4positive regulation of immature T cell proliferation in thymusGO:003309210.3FOXP3, IL1B
5neutrophil apoptotic processGO:000178110.3IFNG, IL6
6receptor biosynthetic processGO:003280010.3IL10, TNF
7positive regulation of regulatory T cell differentiationGO:004559110.2FOXP3, IL2
8negative regulation of cytokine secretion involved in immune responseGO:000274010.2IL10, TNF
9positive regulation of T cell proliferationGO:004210210.2IFNG, IL2, IL4
10myeloid cell homeostasisGO:000226210.1FOXP3, IL6
11sequestering of triglycerideGO:003073010.1IL1B, TNF
12response to yeastGO:000187810.1CALCA, IL6
13regulation of establishment of endothelial barrierGO:190314010.1IL1B, TNF
14positive regulation of isotype switching to IgG isotypesGO:004830410.1IFNG, IL2, IL4
15positive regulation of fever generationGO:003162210.1IL1B, TNF
16negative regulation of lipid catabolic processGO:005099510.1IL1B, TNF
17epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.0IL6, TNF
18extrinsic apoptotic signaling pathway in absence of ligandGO:009719210.0IL1B, IL2, IL4
19negative regulation of tumor necrosis factor productionGO:003272010.0FOXP3, IL10, PTPN22
20negative regulation of inflammatory responseGO:005072810.0FOXP3, IL10, IL2
21negative regulation of lipid storageGO:00108889.9IL6, TNF
22positive regulation of MHC class II biosynthetic processGO:00453489.9IFNG, IL10, IL4
23negative regulation of growth of symbiont in hostGO:00441309.8IFNG, IL10, TNF
24positive regulation of calcidiol 1-monooxygenase activityGO:00605599.8IFNG, IL1B, TNF
25positive regulation of membrane protein ectodomain proteolysisGO:00510449.8IFNG, IL1B, TNF
26T cell chemotaxisGO:00108189.7CXCL10, CXCL11
27negative regulation of interleukin-6 productionGO:00327159.7FOXP3, IL10, TNF
28positive regulation of interferon-gamma productionGO:00327299.7IL1B, IL2, TNF
29regulation of insulin secretionGO:00507969.6IFNG, IL1B, TNF
30positive regulation of chemokine biosynthetic processGO:00450809.5IFNG, IL1B, IL4, TNF
31defense response to protozoanGO:00428329.5IFNG, IL10, IL4, IL6
32positive regulation of nitric oxide biosynthetic processGO:00454299.5IL1B, IL6, TNF
33chemotaxisGO:00069359.4CXCL10, CXCL11, IL4
34defense response to bacteriumGO:00427429.3IFNG, IL10, TNF
35positive regulation of protein phosphorylationGO:00019349.2IL1B, IL2, IL4, TNF
36positive regulation of interleukin-6 productionGO:00327559.2IL1B, IL6, TNF
37positive regulation of apoptotic processGO:00430659.2IL1B, IL6, TNF
38agingGO:00075689.1CALCA, IL10, IL1B, IL6
39response to glucocorticoidGO:00513849.0IL10, IL1B, IL6, TNF
40positive regulation of cell proliferationGO:00082848.8CXCL10, IFNG, IL2, IL4, IL6
41cellular response to lipopolysaccharideGO:00712228.7IFNG, IL1B, IL6, TNF
42positive regulation of gene expressionGO:00106288.6FOXP3, IFNG, IL1B, IL6
43positive regulation of sequence-specific DNA binding transcription factor activityGO:00510918.6IL10, IL1B, IL4, IL6, TNF
44response to drugGO:00424938.6IFNG, IL10, IL1B, IL4, IL6
45cell-cell signalingGO:00072678.3CALCA, CXCL10, CXCL11, IL10, IL1B, IL2
46inflammatory responseGO:00069548.2CALCA, CXCL10, IL10, IL1B, IL6, TNF
47positive regulation of transcription, DNA-templatedGO:00458937.9FOXP3, IFNG, IL10, IL1B, IL4, IL6
48response to lipopolysaccharideGO:00324967.3CXCL10, CXCL11, IL10, IL1B, IL6, PTPN22
49positive regulation of transcription from RNA polymerase II promoterGO:00459446.8CXCL10, FOXP3, IFNG, IL10, IL1B, IL2
50immune responseGO:00069556.7CXCL10, CXCL11, IFNG, IL10, IL1B, IL2

Sources for Autoimmune Thyroiditis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet